Commentary

You have full text access to this OnlineOpen article

Increased risk of brain metastases in patients with HER-2/neu-positive breast carcinoma

  1. Ramin Altaha M.D.†,*,
  2. Edward Crowell M.D.,
  3. Gerry Hobbs Ph.D.,
  4. Gerry Higa Pharm.D.,
  5. Jame Abraham M.D.

Article first published online: 1 DEC 2004

DOI: 10.1002/cncr.20813

Issue

Cancer

Cancer

Volume 103, Issue 3, pages 442–443, 1 February 2005

Additional Information

How to Cite

Altaha, R., Crowell, E., Hobbs, G., Higa, G. and Abraham, J. (2005), Increased risk of brain metastases in patients with HER-2/neu-positive breast carcinoma. Cancer, 103: 442–443. doi: 10.1002/cncr.20813

Author Information

  1. Section of Hematology/Oncology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, West Virginia

  1. †

    Fax: (304) 293-2519

*Section of Hematology/Oncology, Mary Babb Randolph Cancer Center, Robert C. Byrd Health Sciences Center, West Virginia University Hospitals, P.O. Box 9162, Morgantown, WV 26506-9162

Publication History

  1. Issue published online: 20 JAN 2005
  2. Article first published online: 1 DEC 2004
  3. Manuscript Revised: 8 OCT 2004
  4. Manuscript Accepted: 8 OCT 2004
  5. Manuscript Received: 21 JUN 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (40K)

REFERENCES

  • 1
    Kallioniemi OP, Holli K, Visakorpi T, Koivula T, Helin HH, Isola JJ. Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer. Int J Cancer. 1991; 49: 650–655.
    Direct Link:
  • 2
    Bendell JC, Domchek SM, Burstein HJ, et al. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer. 2003; 97: 2972–2977.
    Direct Link:
  • 3
    Shmueli E, Wigler N, Inbar M. Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment. Eur J Cancer. 2004; 40: 379–382.
  • 4
    Pestalozzi BC, Brignoli S. Trastuzumab in CSF. J Clin Oncol. 2000; 18: 2349–2351.
  • 5
    Baculi RH, Suki S, Nisbett J, Leeds N, Groves M. Meningeal carcinomatosis from breast carcinoma responsive to trastuzumab. J Clin Oncol. 2001; 19: 3297–3298.
  • 6
    Lower EE, Drosick DR, Blau R, Brennan L, Danneman W, Hawley DK. Increased rate of brain metastasis with trastuzumab therapy not associated with impaired survival. Clin Breast Cancer. 2003; 4: 114–119.
View Full Article (HTML) Get PDF (40K)